These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 21531745)

  • 1. Reversibility of rocuronium-induced profound neuromuscular block with sugammadex in younger and older patients.
    Suzuki T; Kitajima O; Ueda K; Kondo Y; Kato J; Ogawa S
    Br J Anaesth; 2011 Jun; 106(6):823-6. PubMed ID: 21531745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of rocuronium-induced neuromuscular block with sugammadex is faster than reversal of cisatracurium-induced block with neostigmine.
    Flockton EA; Mastronardi P; Hunter JM; Gomar C; Mirakhur RK; Aguilera L; Giunta FG; Meistelman C; Prins ME
    Br J Anaesth; 2008 May; 100(5):622-30. PubMed ID: 18385265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between cardiac output and reversibility of rocuronium-induced moderate neuromuscular block with sugammadex.
    Yoshida F; Suzuki T; Kashiwai A; Furuya T; Konishi J; Ogawa S
    Acta Anaesthesiol Scand; 2012 Jan; 56(1):83-7. PubMed ID: 22103864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of profound rocuronium-induced blockade with sugammadex: a randomized comparison with neostigmine.
    Jones RK; Caldwell JE; Brull SJ; Soto RG
    Anesthesiology; 2008 Nov; 109(5):816-24. PubMed ID: 18946293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recovery of laryngeal nerve function with sugammadex after rocuronium-induced profound neuromuscular block.
    Pavoni V; Gianesello L; Martinelli C; Horton A; Nella A; Gori G; Simonelli M; De Scisciolo G
    J Clin Anesth; 2016 Sep; 33():14-9. PubMed ID: 27555126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of neuromuscular block with sugammadex: a comparison of the corrugator supercilii and adductor pollicis muscles in a randomized dose-response study.
    Yamamoto S; Yamamoto Y; Kitajima O; Maeda T; Suzuki T
    Acta Anaesthesiol Scand; 2015 Aug; 59(7):892-901. PubMed ID: 25962400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicentre, parallel-group, comparative trial evaluating the efficacy and safety of sugammadex in patients with end-stage renal failure or normal renal function.
    Staals LM; Snoeck MM; Driessen JJ; Flockton EA; Heeringa M; Hunter JM
    Br J Anaesth; 2008 Oct; 101(4):492-7. PubMed ID: 18653492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study.
    de Boer HD; Driessen JJ; Marcus MA; Kerkkamp H; Heeringa M; Klimek M
    Anesthesiology; 2007 Aug; 107(2):239-44. PubMed ID: 17667567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sugammadex rapidly reverses moderate rocuronium- or vecuronium-induced neuromuscular block during sevoflurane anaesthesia: a dose-response relationship.
    Pühringer FK; Gordon M; Demeyer I; Sparr HJ; Ingimarsson J; Klarin B; van Duijnhoven W; Heeringa M
    Br J Anaesth; 2010 Nov; 105(5):610-9. PubMed ID: 20876699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sugammadex given for rocuronium-induced neuromuscular blockade in infants: a retrospectıve study.
    Ozmete O; Bali C; Cok OY; Turk HE; Ozyilkan NB; Civi S; Aribogan A
    J Clin Anesth; 2016 Dec; 35():497-501. PubMed ID: 27871583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sugammadex reversal of rocuronium-induced neuromuscular block in Caesarean section patients: a series of seven cases.
    Pühringer FK; Kristen P; Rex C
    Br J Anaesth; 2010 Nov; 105(5):657-60. PubMed ID: 20736231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy of sugammadex in the reversal of neuromuscular blockade induced by rocuronium in long-duration surgery: under inhaled vs. intravenous anesthesia].
    Veiga-Ruiz G; Domínguez N; Orozco J; Janda M; Hofmockel R; Alvarez-Gómez JA
    Rev Esp Anestesiol Reanim; 2009; 56(6):349-54. PubMed ID: 19725342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, dose-response study of sugammadex given for the reversal of deep rocuronium- or vecuronium-induced neuromuscular blockade under sevoflurane anesthesia.
    Duvaldestin P; Kuizenga K; Saldien V; Claudius C; Servin F; Klein J; Debaene B; Heeringa M
    Anesth Analg; 2010 Jan; 110(1):74-82. PubMed ID: 19933538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of profound rocuronium block monitored in three muscle groups with sugammadex in ponies.
    Mosing M; Auer U; Bardell D; Jones RS; Hunter JM
    Br J Anaesth; 2010 Oct; 105(4):480-6. PubMed ID: 20650917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy and safety of sugammadex (Org 25969) in reversing moderate neuromuscular block induced by rocuronium or vecuronium in Japanese patients].
    Takeda J; Iwasaki H; Yamakage M; Ozaki M; Kawamata M; Hatano Y; Yorozuya T; Miyakawa H; Kanmura Y
    Masui; 2014 Oct; 63(10):1075-82. PubMed ID: 25693332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Org 25969 (sugammadex), a selective relaxant binding agent for antagonism of prolonged rocuronium-induced neuromuscular block.
    Shields M; Giovannelli M; Mirakhur RK; Moppett I; Adams J; Hermens Y
    Br J Anaesth; 2006 Jan; 96(1):36-43. PubMed ID: 16357116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of neuromuscular blockade with sugammadex at the reappearance of four twitches to train-of-four stimulation.
    Pongrácz A; Szatmári S; Nemes R; Fülesdi B; Tassonyi E
    Anesthesiology; 2013 Jul; 119(1):36-42. PubMed ID: 23665915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of sugammadex for the reversal of moderate and deep rocuronium-induced neuromuscular block in patients pretreated with intravenous magnesium: a randomized controlled trial.
    Czarnetzki C; Tassonyi E; Lysakowski C; Elia N; Tramèr MR
    Anesthesiology; 2014 Jul; 121(1):59-67. PubMed ID: 24608361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy and safety of sugammadex (Org 25969) in reversing deep neuromuscular block induced by rocuronium or vecuronium in Japanese patients].
    Takeda J; Iwasaki H; Otagiri T; Katoh T; Shingu K; Obara H; Nakatsuka H; Tomiyama Y; Kasaba T
    Masui; 2014 Oct; 63(10):1083-8. PubMed ID: 25693333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeat dosing of rocuronium 1.2 mg kg-1 after reversal of neuromuscular block by sugammadex 4.0 mg kg-1 in anaesthetized healthy volunteers: a modelling-based pilot study.
    Cammu G; de Kam PJ; De Graeve K; van den Heuvel M; Suy K; Morias K; Foubert L; Grobara P; Peeters P
    Br J Anaesth; 2010 Oct; 105(4):487-92. PubMed ID: 20630888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.